Search Results - "Véronèse, L"

Refine Results
  1. 1

    Interleukin-6 gene amplification and shortened survival in glioblastoma patients by TCHIRKOV, A, KHALIL, T, CHAUTARD, E, MOKHTARI, K, VERONESE, L, IRTHUM, B, VAGO, P, KEMENY, J.-L, VERRELLE, P

    Published in British journal of cancer (12-02-2007)
    “…Interleukin-6 (IL-6) is known to promote tumour growth and survival. We evaluated IL-6 gene amplification in tumours from 53 glioma patients using fluorescence…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population by Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F.

    Published in NPJ precision oncology (20-07-2021)
    “…Neurotrophic tropomyosin receptor kinase ( NTRK) gene fusions are rare oncogenic drivers in solid tumours. This study aimed to interrogate a large real-world…”
    Get full text
    Journal Article
  7. 7

    Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities by Gouas, L., Goumy, C., Véronèse, L., Tchirkov, A., Vago, P.

    Published in Pathologie biologie (Paris) (01-09-2008)
    “…Cytogenetics is the part of genetics that deals with chromosomes, particularly with numerical and structural chromosome abnormalities, and their implications…”
    Get full text
    Journal Article
  8. 8

    THE ‘MASSERIA ROTA’ IN NAPLES (ITALY). A VERNACULAR HERITAGE TO PRESERVE by Amore, R., Veronese, L.

    “…The ‘Masseria Rota’ in Cercola, near Naples, is one of the best-preserved examples of the important vernacular architectural heritage of the Vesuvian area…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    SPECIFITY OF HISTORICAL BUILDINGS AND BIM METHODOLOGIES. A FIRST EXPERIMENTATION FOR THE FEDERICO II HEADQUARTERS IN NAPLES by Picone, R., Veronese, L.

    “…The Building Information Modeling is today one of the most advanced data cataloging and processing systems aimed to the digital representation of physical and…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH) by Lefebvre, C., Veronese, L., Nadal, N., Gaillard, J.-B., Penther, D., Daudignon, A., Chauzeix, J., Nguyen-Khac, F., Chapiro, E.

    Published in Current research in translational medicine (01-10-2023)
    “…Non-Hodgkin lymphomas (NHL) consist of a wide range of clinically, phenotypically and genetically distinct neoplasms. The accurate diagnosis of mature B-cell…”
    Get full text
    Journal Article Book Review
  11. 11

    Lactation performance of Holstein cows treated with 2 formulations of recombinant bovine somatotropin in a large commercial dairy herd in Brazil by de Morais, J P G, da S Cruz, A P, Minami, N S, Veronese, L P, Del Valle, T A, Aramini, J

    Published in Journal of dairy science (01-07-2017)
    “…The objectives of this controlled study were to compare the effects of 2 different formulations of recombinant bovine somatotropin (rbST) on milk yield, milk…”
    Get more information
    Journal Article
  12. 12

    The incidence of postoperative nausea and vomiting after caesarean section in patients with hyperemesis gravidarum: a retrospective cohort study by Jacobs, N.F., Veronese, L.R., Okano, S., Hurst, C., Dyer, R.A.

    “…•Retrospective study of patients with hyperemesis gravidarum and caesarean delivery.•Higher incidence of postoperative nausea and vomiting in patients with…”
    Get full text
    Journal Article
  13. 13

    Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications by Krebs, M.G., Blay, J.-Y., Le Tourneau, C., Hong, D., Veronese, L., Antoniou, M., Bennett, I.

    Published in ESMO open (01-04-2021)
    “…Entrectinib is a tropomyosin receptor kinase inhibitor approved for the treatment of neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours…”
    Get full text
    Journal Article
  14. 14

    Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers by Véronèse, L, Tchirkov, A, Gouas, L, Périssel, B, Goumy, C, Vago, P

    Published in Annales de biologie clinique (Paris) (01-07-2008)
    “…Early stages of chronic lymphocytic leukemia (CLL), which are the most frequent at diagnosis, have an extremely variable individual prognosis, as some patients…”
    Get more information
    Journal Article
  15. 15

    Exposure-Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice by Veronese, Maria L., Gillen, Lisa P., Burke, Joanne P., Dorval, Ellen P., Hauck, Walter W., Pequignot, Ed, Waldman, Scott A., Greenberg, Howard E.

    Published in Journal of clinical pharmacology (01-08-2003)
    “…Consumption of typical quantities of grapefruit juice (GFJ) increases the oral bioavailability of several CYP3A4 substrates without affecting their…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival by Simonato, L. E., Garcia, J. F., Sundefeld, M. L. M. M., Mattar, N. J., Veronese, L. A., Miyahara, G. I.

    Published in Journal of oral pathology & medicine (01-11-2008)
    “…The human papillomavirus (HPV) has been historically associated with head and neck cancers, although its role in oral carcinogenesis remains poorly defined…”
    Get full text
    Journal Article
  19. 19

    A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer by VERONESE, M. L, SUN, W, GIANTONIO, B, BERLIN, J, SHULTS, J, DAVIS, L, HALLER, D. G, O'DWYER, P. J

    Published in British journal of cancer (23-05-2005)
    “…Inhibition of epidermal growth factor receptor (EGFR) signalling contributes to the therapy of colorectal cancer. Gefitinib, an oral EGFR tyrosine kinase…”
    Get full text
    Journal Article
  20. 20

    Familial deletion 11q14.3–q22.1 without apparent phenotypic consequences: A haplosufficient 8.5 Mb region by Goumy, C., Gouas, L., Tchirkov, A., Roucaute, T., Giollant, M., Veronèse, L., Francannet, C., Vago, P.

    “…We present the prenatal diagnosis of a chromosome 11q14.3–q22.1 deletion identified in three generations without apparent phenotypic consequences. A…”
    Get full text
    Journal Article